1.Research on the Relationship Between Bronchial Asthma and Tuberculin Reaction
Journal of Chinese Physician 2001;0(07):-
Objective To study the relationship between bronchial asthma and tuberculin reaction.Methods The concentractions of serum IgE,IFN-? were determined by ELISA,then obtained data was compared with results of tuberculin reaction.Results ⑴Tuberculin reaction of the patients with asthma almost all showed negative,however the patients with tuberculin showed positive,even strong positive.⑵As compared patients with tuberculi reaction negative,the concentration of serum IgE in tuberculin reaction positive patients was lower,but the concentration of serum IFN-? was higher.Conclusions The Th1 cells immune function is reduced in the bronchial asthma patients,but elevation of Th2 cells immune function.
2.Effect of budesonide and doxofylline on patients with moderate persistent asthma
Zhuochang CHEN ; Juanjuan DING ; Haoyu QIAN ; Xianghua LIN ; Keqing FENG ; Jing WANG
The Journal of Practical Medicine 2014;(24):4015-4017
Objective To observe the effect of budesonide/doxofylline on patients with persistent asthma. Methods Sixty patients with moderate asthma were randomly divided into treatment group and control group. Patients in treatment group accepted the inhalation budesonide 400μg/d and doxofylline tablet 0.2 bid po but those in control group accepted the inhalation budesonide/formoterol 160/4.5μg bid. FeNO, sputum eosinophils, PEF and ACT scores were compared between two groups. Results PEF and ACT scores in treatment group were lower to those in control group (P<0.05), whereas the score of sputum eosinophils in treatment group was higher (P<0.05) one month later. There was no significant difference in FeNO between two groups (P>0.05). After three months, sputum eosinophils in treatment group were better than that in control group (P<0.05), whereas there was no significant difference in PEF, ACT scores and FeNO between two groups(P>0.05). Conclusion There is no significant difference in controlling asthma between budesonide/doxofylline and budesonide/formooterol
3.A Three-Month Non-Interventional Study of Asthma Treatment with Budesonide/Formoterol
Xin ZHOU ; Jianguo HONG ; Jianbao XIN ; Changgui WU ; Jianping BO ; Tiantuo ZHANG ; Changzheng WANG ; Shaoxi CAI ; Chan LIU ; Chea QIU ; Jianan HUANG ; Guoxiang LAI ; Lingfei KONG ; Chuntao LIU ; Zhaang MA ; Kewu HUANG ; Heping FANG ; Jianying ZHOU ; Zhuochang CHENG ; Peizong SUN ; Genyun SUN ; Libo WANG ; Suping TANG ; Zhimia CHEN ; Changchong LI ; Deyu ZHAO ; Rongjun LIN ; Yuefie ZHENG ; Li XIANG ; Xiaoqing ZHOU ; Yuzhi CHENG
Chinese Journal of Respiratory and Critical Care Medicine 2009;8(4):341-344
Objective To evaluate the efficacy of Budesonide/formoterol to control asthma under real-life conditions.Methods A muhi-center, open label, non-interventional study was conducted.Asthma control after 12 week therapy with Budesonide/formoterol was assessed by Asthma Control Questionnaire (ACQ) and modified Asthma Control Questionnaire (ACQ5).Results A total of 360 asthma patients were recruited,including 228 adult patients and 132 child patients.After 12 weeks' therapy,all the patients' medium value of ACQ was decreased significantly from 2.03 (adults 2.20, children 1.74) at baseline to 0.60 (adults 0.78, children 0.29) (P < 0.0001), and the medium value of ACQ5 was also decreased significantly from 2.4 (adults 2.24, children 1.76) at baseline to 0.47 (adults 0.62, children 0.20) (P < 0.0001).Conclusion Budesonide/formoterol is effective in asthma treatment, by which most asthma patients obtain and maintain clineal control.
4.Hospitalization Due to Asthma Exacerbation: A China Asthma Research Network (CARN) Retrospective Study in 29 Provinces Across Mainland China
Jiangtao LIN ; Bin XING ; Huaping TANG ; Lan YANG ; Yadong YUAN ; Yuhai GU ; Ping CHEN ; Xiaoju LIU ; Jie ZHANG ; Huiguo LIU ; Changzheng WANG ; Wei ZHOU ; Dejun SUN ; Yiqiang CHEN ; Zhuochang CHEN ; Mao HUANG ; Qichang LIN ; Chengping HU ; Xiaohong YANG ; Jianmin HUO ; Xianwei YE ; Xin ZHOU ; Ping JIANG ; Wei ZHANG ; Yijiang HUANG ; Luming DAI ; Rongyu LIU ; Shaoxi CAI ; Jianying XU ; Jianying ZHOU ;
Allergy, Asthma & Immunology Research 2020;12(3):485-495
PURPOSE: Details of patients hospitalized for asthma exacerbation in mainland China are lacking. To improve disease control and reduce economic burden, a large sample survey among this patient population is indispensable. This study aimed to investigate the clinical characteristics and outcomes of such patients.METHODS: A retrospective study was conducted on patients hospitalized for asthma exacerbation in 29 hospitals of 29 regions in mainland China during the period 2013 to 2014. Demographic features, pre-admission conditions, exacerbation details, and outcomes were summarized. Risk factors for exacerbation severity were analyzed.RESULTS: There were 3,240 asthmatic patients included in this study (57.7% females, 42.3% males). Only 28.0% used daily controller medications; 1,287 (39.7%) patients were not currently on inhaled corticosteroids. Acute upper airway infection was the most common trigger of exacerbation (42.3%). Patients with severe to life-threatening exacerbation tended to have a longer disease course, a smoking history, and had comorbidities such as hypertension, chronic obstructive pulmonary disease (COPD), and food allergy. The multivariate analysis showed that smoking history, comorbidities of hypertension, COPD, and food allergy were independent risk factors for more severe exacerbation. The number of patients hospitalized for asthma exacerbation varied with seasons, peaking in March and September. Eight patients died during the study period (mortality 0.25%).CONCLUSIONS: Despite enhanced education on asthma self-management in China during recent years, few patients were using daily controller medications before the onset of their exacerbation, indicating that more educational efforts and considerations are needed. The findings of this study may improve our understanding of hospital admission for asthma exacerbation in mainland China and provide evidence for decision-making.
Adrenal Cortex Hormones
;
Asthma
;
China
;
Comorbidity
;
Disease Progression
;
Education
;
Female
;
Food Hypersensitivity
;
Hospitalization
;
Humans
;
Hypertension
;
Inpatients
;
Medication Adherence
;
Mortality
;
Multivariate Analysis
;
Pulmonary Disease, Chronic Obstructive
;
Retrospective Studies
;
Risk Factors
;
Seasons
;
Self Care
;
Smoke
;
Smoking